维普期刊资源整合服务平台（V6.5）

147篇 您的检索式：作者名="Buchdunger"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742,in combination with STI571,delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling显示文摘	Warshamana-Greene GS Litz J Buchdunger E	2004	Mol Cancer Ther2004，3，5：	1
2	Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr2Abl positive cells显示文摘	Druker B J Tamura S Buchdunger E	1996	Nature Med1996，2，5：	1
3	C-livec (ST1571, imatinib), a rationally developed, targeted antican cer drug显示文摘	Capdeville R Buchdunger E Zimmermann J	2002	Nat Rev Drug Discov2002，1，7：	1
4	The development of irnatinib as a therapeutic agent for chronic myeloid leukemia 显示文摘	DEININGER M BUCHDUNGER E DRUKER BJ	2005	Blood2005，105，7：	1
5	Pharmacology of imatinib(STI571)显示文摘	Buchdunger E Oreilly T Wood J	2002	Eur J Cancer2002，38，5：	1
6	Inhibition of the Abl protein tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative显示文摘	Buchdunger E Zimmermann J Mett H	1996	Cancer Res1996，56，1：	1
7	Effects of a selective inhibitor of the ABL tyrosine kinase on the growth of Bcr - Abl positive cells显示文摘	Druker B Tamura S Buchdunger E		Nature Medicine0，，：	1
8	Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells显示文摘	Druker BJ Tamura S Buchdunger E	1996	Nat Med1996，2，：	1
9	Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells显示文摘	Druker B J Tamura S Buchdunger E	1996	Nat Med1996，2，：	1
10	Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors显示文摘	Buchdunger E Cioffi CL Law N	2000	J Pharmacol Exp Ther2000，295，1：	1
11	Pharmacology of imatinib (STI571) 显示文摘	Buchdunger E OReilly T Wood J	2002	Eur J Cancer2002，38，5：	1
12	a novel and potent inhibitorof vascular endothelial growth factor receptor tyrosine kinases,im-pairs vascular endothelial growth factor-induced responses andtumor growth after oral administration显示文摘	Wood JM Bold G Buchdunger E	2000	Cancer Res2000，60，3：	1
13	Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-Kit and platelet-derived growth factor receptors 显示文摘	Buchdunger E Cioffi CL Law N	2000	J pharmacol Exp Ther2000，295，1：	1
14	Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells显示文摘	Druker BJ Tamura S Buchdunger E	1996	Nat Med1996，2，5：	1
15	Inhibition of the ABL protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative 显示文摘	Buchdunger E Zimmermann J Mett H	1996	Cancer Res1996，56，1：	1
16	The development of imatinib as a therapeutic agent for chronic myeloid显示文摘	Deininger M Buchdunger E Druker BJ	2005	Blood2005，105，7：	1
17	The development of ima- tinib as a therapeutic agent for chronic myeloid 显示文摘	Deininger M Buchdunger E Druker BJ	2005	Blood2005，105，7：	1
18	Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative显示文摘	Zimmermann J Mett H	1996	Cancer Res1996，56，1：	1
19	Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells显示文摘	Druker BJ Tamura S Buchdunger E	1996	Nat Med1996，2，5：	1
20	Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells显示文摘	Tamura S Buchdunger E	1996	Nature Med1996，2，5：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示